Publication: Dual action-based approaches to antibacterial agents
0
0
Issued Date
2007
Resource Type
File Type
application/pdf
ISSN
9298673
Other identifier(s)
2-s2.0-34250160226
Rights Holder(s)
Scopus
Bibliographic Citation
Current Medicinal Chemistry. Vol 14, No.13 (2007), p.1459-1477
Suggested Citation
Bremner J.B., Ambrus J.I., Samosorn S. Dual action-based approaches to antibacterial agents. Current Medicinal Chemistry. Vol 14, No.13 (2007), p.1459-1477. doi:10.2174/092986707780831168 Retrieved from: https://hdl.handle.net/20.500.14740/4556
Author(s)
Abstract
This review collates and analyses recent work done on dual action approaches to tackling the mounting health problem of resistance by human pathogenic bacteria to antibacterial agents. In particular the areas reviewed include the use of two drugs in combination, dual action prodrugs, and dual action drugs (or hybrid drugs). © 2007 Bentham Science Publishers Ltd.
Subject(s)
Aminoglycoside antibiotic agent
Amoxicillin
Amoxicillin plus clavulanic acid
Antiinfective agent
Beta lactam
Cefamandole
Cefotaxime
Cephalosporin
Chloramphenicol
Ciprofloxacin
Clarithromycin
Cotrimoxazole
Cytotoxic agent
Dalfopristin plus quinupristin
Enrofloxacin
Erythromycin
Fleroxacin
Gatifloxacin
Macrolide
Mitozolomide
Norfloxacin
Omeprazole
Penicillin G
Prodrug
Quinoline derived antiinfective agent
Rifampicin
Temozolomide
Triclosan
Unindexed drug
Vancomycin
Antibacterial activity
Antibiotic resistance
Bacterial infection
Drug design
Drug efficacy
Human
Minimum inhibitory concentration
Nonhuman
Respiratory tract infection
Review
Septicemia
Skin infection
Urinary tract infection
Wound infection
Anti-Bacterial Agents
Bacteria
Models, Molecular
Prodrugs
Structure-Activity Relationship
Amoxicillin
Amoxicillin plus clavulanic acid
Antiinfective agent
Beta lactam
Cefamandole
Cefotaxime
Cephalosporin
Chloramphenicol
Ciprofloxacin
Clarithromycin
Cotrimoxazole
Cytotoxic agent
Dalfopristin plus quinupristin
Enrofloxacin
Erythromycin
Fleroxacin
Gatifloxacin
Macrolide
Mitozolomide
Norfloxacin
Omeprazole
Penicillin G
Prodrug
Quinoline derived antiinfective agent
Rifampicin
Temozolomide
Triclosan
Unindexed drug
Vancomycin
Antibacterial activity
Antibiotic resistance
Bacterial infection
Drug design
Drug efficacy
Human
Minimum inhibitory concentration
Nonhuman
Respiratory tract infection
Review
Septicemia
Skin infection
Urinary tract infection
Wound infection
Anti-Bacterial Agents
Bacteria
Models, Molecular
Prodrugs
Structure-Activity Relationship